Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells

References

• Agil, A., et al., 2020. Melatonin improves mitochondrial dynamics and function in the kidney of zücker diabetic fatty rats. Journal of clinical medicine, 9 (9), 2916.
   Google Scholar
• Alicic, R.Z., Rooney, M.T., and Tuttle, K.R., 2017. Diabetic kidney disease: challenges, progress, and possibilities. Clinical journal of the American society of nephrology, 12 (12), 2032–2045.
   PubMed Web of Science ®Google Scholar
• Anders, H.J., et al., 2018. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nature reviews. nephrology, 14 (6), 361–377.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal, J., and Jaisser, F., 2020. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets. Diabetes, obesity and metabolism, 22 (S1), 16–31.
   PubMedGoogle Scholar
• Carlisle, R.E., et al., 2021. TDAG51 induces renal interstitial fibrosis through modulation of TGF-β receptor 1 in chronic kidney disease. Cell death and disease, 12 (10), 921.
   PubMed Web of Science ®Google Scholar
• Chang, A.S., et al., 2016. Transforming growth factor-β1 and diabetic nephropathy. American journal of physiology. renal physiology, 310 (8), F689–F696.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2014. ER stress triggers MCP-1 expression through SET7/9-induced histone methylation in the kidneys of db/db mice. American journal of physiology. renal physiology, 306 (8), F916–25.
   PubMed Web of Science ®Google Scholar
• Chen, S., et al., 2011. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. The journal of biological chemistry, 286 (37), 32775–32789.
   PubMedGoogle Scholar
• Di Paolo, S., et al., 1996. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. The American journal of pathology, 149 (6), 2095–2106.
   PubMedGoogle Scholar
• Fang, L., et al., 2013. Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells. PLoS One, 8 (8), e72344.
   PubMedGoogle Scholar
• Foresto-Neto, O., et al., 2020. NF-κB system is chronically activated and promotes glomerular injury in experimental type 1 diabetic kidney disease. Frontiers in physiology, 11, 84–84.
   PubMedGoogle Scholar
• Fu, H., et al., 2019. Diabetic kidney diseases revisited: A new perspective for a new era. Molecular metabolism, 30, 250–263.
   PubMedGoogle Scholar
• Furuya, F., Ishii, T., and Kitamura, K., 2019. Chronic Inflammation and Progression of Diabetic Kidney Disease. Contributions to nephrology, 198, 33–39.
   PubMedGoogle Scholar
• Guo, Q., et al., 2016. Histone lysine methylation in TGF-β1 mediated p21 gene expression in rat mesangial cells. BioMed research international, 2016, 6927234.
   PubMedGoogle Scholar
• Han, B., et al., 2021. Roles of SET7/9 and LSD1 in the pathogenesis of arsenic-induced hepatocyte apoptosis. Journal of clinical and translational hepatology, 9 (3), 364–372.
   PubMedGoogle Scholar
• Hayashida, T., and Schnaper, H.W., 2004. High ambient glucose enhances sensitivity to TGF-β1 via extracellular signal—regulated kinase and protein kinase Cδ activities in human mesangial cells. Journal of the American society of nephrology : JASN, 15 (8), 2032–2041.
   PubMedGoogle Scholar
• Hirano, T., et al., 2018. Development of novel inhibitors for histone methyltransferase SET7/9 based on cyproheptadine. ChemMedChem., 13 (15), 1530–1540.,
   PubMedGoogle Scholar
• Kanasaki, K., Taduri, G., and Koya, D., 2013. Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Frontiers in Endocrinology, 4, 1–15.
   PubMedGoogle Scholar
• Kato, M., and Natarajan, R., 2019. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nature reviews. nephrology, 15 (6), 327–345.
   PubMed Web of Science ®Google Scholar
• Lee, E.S., et al., 2016. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrology, dialysis, transplantation: official Publication of the European Dialysis and Transplant Association – European Renal Association, 31 (3), 391–400.
   PubMed Web of Science ®Google Scholar
• Li, J.H., et al., 2003. Role of TGF-β signalling in extracellular matrix production under high glucose conditions. Kidney international, 63 (6), 2010–2019.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2008. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. The journal of biological chemistry, 283 (39), 26771–26781.
   PubMed Web of Science ®Google Scholar
• Li, Z., et al., 2017. Valproate attenuates endoplasmic reticulum stress-induced apoptosis in SH-SY5Y cells via the AKT/GSK3β signaling pathway. International journal of molecular sciences, 18 (2), 315.
   Google Scholar
• Lin, Y.-C., et al., 2018. Update of pathophysiology and management of diabetic kidney disease. Journal of the formosan medical association = Taiwan yi Zhi, 117 (8), 662–675.
   PubMed Web of Science ®Google Scholar
• Lindenmeyer, M.T., et al., 2008. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. Journal of the American society of nephrology : JASN, 19 (11), 2225–2236.
   PubMed Web of Science ®Google Scholar
• Lu, H.-C., Dai, W.-N., and He, L.-Y., 2021. Epigenetic histone modifications in the pathogenesis of diabetic kidney disease. Diabetes, metabolic syndrome and obesity : targets and therapy, 14, 329–344.
   PubMed Web of Science ®Google Scholar
• Okabe, J., et al., 2012. Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circulation Research, 110 (8), 1067–1076.
   PubMedGoogle Scholar
• Paneni, F., et al., 2015. Adverse epigenetic signatures by histone methyltransferase set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circulation. cardiovascular genetics, 8 (1), 150–158.
   PubMedGoogle Scholar
• Qi, W., et al., 2011. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism: clinical and Experimental, 60 (5), 594–603.
   PubMed Web of Science ®Google Scholar
• Sasaki, K., et al., 2016. Inhibition of SET domain-containing lysine methyltransferase 7/9 ameliorates renal fibrosis. Journal of the American society of nephrology, 27 (1), 203–215.
   PubMedGoogle Scholar
• Sharma, D., et al., 2019. Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signalling. Biomedicine and pharmacotherapy = biomedecine and pharmacotherapie, 109, 1610–1619.
   PubMed Web of Science ®Google Scholar
• Shima, H., et al., 2017. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways. Scientific reports, 7 (1), 1884.
   PubMedGoogle Scholar
• Sun, G., et al., 2010. Epigenetic histone methylation modulates fibrotic gene expression. Journal of the American society of nephrology: JASN, 21 (12), 2069–2080.
   PubMed Web of Science ®Google Scholar
• Takemoto, Y., et al., 2016. Identification of cyproheptadine as an inhibitor of SET domain containing lysine methyltransferase 7/9 (set7/9) that regulates estrogen-dependent transcription. Journal of medicinal chemistry, 59 (8), 3650–3660.
   PubMed Web of Science ®Google Scholar
• Tamura, R., et al., 2018. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis. PLoS One, 13 (5), e0196844.
   PubMed Web of Science ®Google Scholar
• Tong, Y., et al., 2018. The protective effect of shikonin on renal tubular epithelial cell injury induced by high glucose. Biomedicine and pharmacotherapy = biomedecine and pharmacotherapie, 98, 701–708.
   PubMed Web of Science ®Google Scholar
• Wada, J., and Makino, H., 2013. Inflammation and the pathogenesis of diabetic nephropathy. Clinical science (London, England: 1979), 124 (3), 139–152.
   PubMed Web of Science ®Google Scholar
• Wang, M., 2021. Reducing stress-induced CHOP is renoprotective. Nature reviews. nephrology, 17 (11), 707–707.
   Google Scholar
• Wang, W.W., et al., 2021. Inhibition of renal tubular epithelial mesenchymal transition and endoplasmic reticulum stress-induced apoptosis with shenkang injection attenuates diabetic tubulopathy. Frontiers in pharmacology, 12, 662706.
   PubMedGoogle Scholar
• Yamazaki, T., et al., 2021. Treatment of diabetic kidney disease: current and future. Diabetes and metabolism journal, 45 (1), 11–26.
   PubMed Web of Science ®Google Scholar
• Yu, C., and Zhuang, S., 2019. Histone methyltransferases as therapeutic targets for kidney diseases. Frontiers in pharmacology, 10, 1393–1393.
   PubMedGoogle Scholar
• Yunlei, D., et al., 2018. Transient high-glucose stimulation induces persistent inflammatory factor secretion from rat glomerular mesangial cells via an epigenetic mechanism. Cellular physiology and biochemistry, 49 (5), 1747–1754.
   PubMedGoogle Scholar
• Zhao, L., Zou, Y., and Liu, F., 2020. Transforming growth factor-beta1 in diabetic kidney disease. Frontiers in cell and developmental biology, 8, 187.
   PubMed Web of Science ®Google Scholar
• Zheng, W., Guo, J., and Liu, Z.-S., 2021. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Clinical epigenetics, 13 (1), 87.
   PubMed Web of Science ®Google Scholar